IFLR1000

News and features

Articles

Article type
Jurisdiction
Practice area

Showing 1 - 10 of 105

News & Analysis

Switzerland: Bär & Karrer Advises SK Capital LP on the Acquisition of Swixx BioPharma Holding AG

15 December 2025 by Bär & Karrer - Switzerland

The US private equity investor SK Capital LP has acquired the Swixx BioPharma Group. The Swixx BioPharma Group is a leading global full-service partner in the distribution of biopharmaceutical products, particularly in Central and Eastern Europe and Latin America.
News & Analysis

Switzerland: Bär & Karrer Strengthens Leadership Team and Showcases Commitment to Growing with Internal Talents

15 December 2025 by Bär & Karrer - Switzerland

Bär & Karrer is pleased to announce the election of Abdul Carrupt, Predrag Sunaric and Stephanie Walter as partners, effective 1 January 2026.
News & Analysis

Switzerland: Bär & Karrer Advises Tertianum on the Acquisition of Senevita Group

12 December 2025 by Bär & Karrer - Switzerland

The Tertianum Group is acquiring Senevita AG. This transaction will see two long- standing Swiss providers in the field of residential care and nursing for the elderly join forces.

News & Analysis

Switzerland: Bär & Karrer Advises Vontobel on the Sale of the Cosmofunding Platform to Zürcher Kantonalbank

12 December 2025 by Bär & Karrer - Switzerland

On 29 October 2025 Vontobel signed an agreement to sell its capital markets platform, Cosmofunding, to Zürcher Kantonalbank.

News & Analysis

Switzerland: Bär & Karrer advised Tecan on the issuance of CHF 150 Million bonds

11 December 2025 by Bär & Karrer - Switzerland

On 14 August 2025 Tecan Group Ltd. (SIX Swiss Exchange: TECN) successfully issued CHF 150 million 0.85% fixed rate domestic straight bonds due 2030.
News & Analysis

Bär & Karrer Advises Valora on its Share Placement

23 November 2020 by Bär & Karrer

Valora Holding AG completed a placement of shares
News & Analysis

Bär & Karrer Advised Credit Suisse, J.P. Morgan and BofA Securities in the Rights Offering of Idorsia.

28 October 2020 by Bär & Karrer

On 23 October 2020, Idorsia Ltd completed a capital increase by way of an at-market rights offering.
News & Analysis

Bär & Karrer Advises the Managers in CHF 18.6 Million Rights Offering of Kuros Biosciences.

26 October 2020 by Bär & Karrer

On 23 October 2020, Kuros Biosciences, a life science company focusing on the development and marketing of orthobiologics
News & Analysis

Bär & Karrer Advises Patrimonium on the Acquisition of a Majority Stake in the ROTH GROUPE

19 October 2020 by Bär & Karrer

Bär & Karrer advised Swiss based Private Equity Fund Patrimonium on the acquisition of a majority stake in
News & Analysis

Bär & Karrer Advises Fideuram – Intesa Sanpaolo Private Banking in the Strategic Partnership with Reyl

13 October 2020 by Bär & Karrer

Bär & Karrer Advises Fideuram – Intesa Sanpaolo Private Banking in the Strategic Partnership with Reyl
Load more